Herbidus Formulations Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.11 M
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -24.09%
- Profit Growth 48.94%
- Ebitda 48.91%
- Net Worth -1807.02%
- Total Assets -22.87%
About Herbidus Formulations
Herbidus Formulations Private Limited (HFPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 15 September 2020 (Four years and five months 10 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.11 M, as per Ministry of Corporate Affairs (MCA) records.
Mahesh Chand, Rajpal Singh, and Deepak Jena serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24232DL2020PTC369976
- Company No.
369976
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Sep 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Herbidus Formulations?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahesh Chand  | Director | 11-Aug-2022 | Current |
| Rajpal Singh | Additional Director | 28-Aug-2023 | Current |
| Deepak Jena | Director | 15-Sep-2020 | Current |
Financial Performance of Herbidus Formulations.
Herbidus Formulations Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 24.09% decrease. The company also saw a substantial improvement in profitability, with a 48.94% increase in profit. The company's net worth observed a substantial decline by a decrease of 1807.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Herbidus Formulations?
In 2023, Herbidus Formulations had a public holding of 5.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ramfin Fortunes Private LimitedMahesh Chand and Rajpal Singh are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Herbidus Formulations?
Herbidus Formulations has a workforce of 0 employees as of Nov 13, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Herbidus Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Herbidus Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
